Lumena Pharmaceuticals, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Lumena Pharmaceuticals, Inc.
Quantité totale PI 13
Rang # Quantité totale PI 120 180
Note d'activité PI 1,7/5.0    8
Rang # Activité PI 115 581
Parent Shire plc
Classe Nice dominante Produits chimiques destinés à l'...

Brevets

Marques

0 5
0 1
6 1
0
 
Dernier brevet 2015 - Bile acid recycling inhibitors f...
Premier brevet 2012 - Bile acid recycling inhibitors f...
Dernière marque 2024 - XENORA
Première marque 2021 - XENORANMN

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 P/S Pharmaceutical agents affecting metabolism; Dietary and nutritional supplements
2021 P/S Chemical compounds for use in the manufacture of pharmaceuticals, dietary supplements, foods and ...
P/S Chemical compounds for use in the manufacture of pharmaceuticals, dietary supplements, foods and...
P/S Dietary supplements; Pharmaceutical agents affecting metabolism
2014 Invention Bile acid recycling inhibitors for treatment of gastrointestinal infections. Provided herein are ...
Invention Bile acid recycling inhibitors for treatment of gastrointestinal infections. Provided herein are...
Invention Bile acid recycling inhibitors for treatment of primary sclerosing cholangitis and inflammatory b...
Invention Bile acid recycling inhibitors for treatment of barrett's esophagus and gastroesophageal reflux d...
2012 Invention Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases. Provided h...
Invention Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease. Pro...
Invention Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease. Prov...
Invention Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases. Provided he...
Invention Bile acid recycling inhibitors for treatment of pancreatitis. Provided herein are methods and co...
Invention Bile acid recycling inhibitors for treatment of pancreatitis. Provided herein are methods and com...